Submission Of Statement Of Number Of Investor Complaints Pending, Received, Disposed-Off And Remaining Unresolved For The Quarter Ended 31St March, 2017.
Pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the statement of Investor Grievances Redressal Mechanism of the Company for the quarter ended 31st March, 2017. Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2017.
Pursuant to the provisions of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find attached the Certificate issued by Mr. Virendra Bhatt, Practicing Company Secretary (Membership No. ACS1157), for the half year ended 31st March, 2017, certifying that all the certificates have been issued within 30 days of the date of lodgement for transfer, sub-division, consolidation, renewal etc., of calls/allotment monies etc. Compliance Certificate Pursuant To Regulation 7 (3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March, 2017
Pursuant to Regulation 7 (3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, confirmation by Company and RTA of compliance of the said provision is enclosed herewith for the half year ended 31st March, 2017 Dr Reddy's Labs to market US-based Integra's neurological products in India
It will distribute Integra's DuraGen Plus and Suturable DuraGen Dural Regeneration in the country Updates
Intimation of loss/ misplaced original share certificate and the subsequent issuance of duplicate share certificates of the Company. Pursuant to Regulation 39 of the SEBI (LODR) Regulations, 2015 and with reference to the captioned subject, we wish to inform you that, we have received an intimation on 17th March, 2017 from M/s. Freedom Registry Limited, Registrar and Transfer Agents of the Company, pertaining to the issuance of duplicate share... Standalone Financial Results, Limited Review Report for December 31, 2016
Integra Garments And Textiles Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016 Board Meeting Intimation for Results & Closure of Trading Window
Integra Garments And Textiles Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on February 10, 2017, inter alia, to consider, approve and take on record the Unaudited Financial Results of the Company and Limited Review Report thereon, for the quarter and period ended December 31, 2016.Further, as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and, in accordance... Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Integra Garments And Textiles Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Shareholding for the Period Ended December 31, 2016
Integra Garments And Textiles Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here Standalone Financial Results, Limited Review Report for September 30, 2016
Integra Garments And Textiles Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 20162. Standalone Limited Review for the period ended September 30, 2016